2018 AVBCC Summit Agenda

AVBCC

October 30-31, 2018 | New York Athletic Club, New York, NY

Tuesday, October 30

6:30 am – 7:30 am Mini-Roundtables
6:30 am – 7:30 am Networking Breakfast | Exhibit Hall
7:30 am Opening Remarks and Greeting
Burt Zweigenhaft, Co-Chair, AVBCC
7:30 am – 8:30 am Keynote: FDA Perspectives
Scott Gottlieb, MD, FDA Commissioner
8:30 am – 9:15 am Tomorrow’s Cancer Care: A Government Policy Perspective
  • Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
  • Faculty: John Michael O’Brien, Advisor to the Secretary & Deputy Assistant Secretary for Health Policy, U.S. Department of Health & Human Services
9:15 am – 10:00 am Tomorrow’s Cancer Care: An Insurance Payer’s Perspective
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Bryan Loy, MD, MBA, Medical Director, Oncology, Laboratory and Personalized Medicine, Humana
    • John Fox, MD, MHA, Senior Medical Director, Priority Health
    • Steve Peskin, MD, MBA, FACP, Executive Medical Director, Population Health, Horizon BCBS
10:00 am – 10:45 am Tomorrow’s Cancer Care: A Center of Excellence Perspective
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Raj Garg, MD, CEO, Cancer Treatment Centers of America
    • Al Benson III, MD, Robert H. Lurie Comprehensive Cancer Center
    • C. Lyn Fitzgerald, SVP, U.S. & Global Development, National Comprehensive Cancer Network
10:45 am – 11:15 am Tomorrow’s Cancer Care: The Community-Based Care Perspective
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Barry Brooks, MD, Medical Director, US Oncology
    • Debra Pratt, MD, MPH, MBA, VP, Texas Oncology
    • Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers
    • Bruce Gould, MD
11:15 am – 12:00 pm Networking Lunch | Exhibit Hall
Keynote
  • Rowdy Gaines, Three-Time Olympic Gold Medalist and NBC Sports Commentator
Distinguished Researchers Panel:
  • Moderator: Neil Canavan, Author, The Cure Within
  • Panelists:
    • Jedd Wolchok, MD, Memorial Sloan Kettering Cancer Center
    • Luis Diaz, MD, Memorial Sloan Kettering Cancer Center
    • Axel Hoos, MD, President, Oncology, GlaxoSmithKline
12:00 pm – 12:45 pm Keynote: Cancer Care into the Future
Greg Simon, President, Biden Cancer Initiative
12:45 pm – 1:30 pm Tomorrow’s Cancer Care: The Employer Perspective
  • Moderator: Jonathan Fassberg, CEO, Solebury Trout
  • Faculty:
    • JPMorgan Chase & Co.
    • PNC Bank
    • Walmart or Amazon
1:30 pm – 2:15 pm Tomorrow’s Cancer Care: A Pharma Perspective
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Mikael Dolsten, MD, President, Worldwide Research & Development, Pfizer
    • Axel Hoos, MD, SVP, Head, Oncology R&D, GlaxoSmithKline
    • Joseph Leveque, Former CMO, ARMO Biosciences
Track 1:
CLINICAL
Track 2:
ADVOCACY
Track 3:
TECHNOLOGY
Track 4:
SUPPLY CHAIN
Track 5:
BUSINESS
Track 6:
CONTRACTING
Track 7:
SPECIALTY PHARMACY
Track 8:
EMPLOYERS
2:15 pm – 3:15 pm
BREAKOUT 1: CLINICAL
CAR-T Gene Therapy Immuno-Oncology
  • Moderator: Morrie Ruffin, CEO, Adjuvant Partners
  • Faculty:
    • Alfred Slanetz, PhD, CEO, Genius Biotechnology
    • Novartis
    • Celgene
BREAKOUT 2: TECHNOLOGY
Artificial Intelligence in Cancer Treatment Design
  • Moderator: Annatasiah Mhaka, PhD, Senior Advisor, Adjuvant Partners
  • Faculty:
    • George Daneker, MD, CMO, Cancer Treatment Centers of America
BREAKOUT 3: SUPPLY CHAIN
Oncology Supply Chain
  • Moderator: Kevin Cast, Partner, Archbow Consulting
  • Faculty:
    • Rusty Massey, VP, Provider Relations, AmerisourceBergen Specialty Group, US Bioservices
    • Patrick Schmidt, CEO, FFF Enterprises
    • Lisa Harrison, Senior Director, Pharmacy and Clinical Services, ION Solutions
BREAKOUT 4: ADVOCACY
Tomorrow’s Cancer Care: The Patient Voice and Advocate Perspective
  • Moderator: Robert Goldberg, PhD, VP, Center for Medicine in the Public Interest
  • Faculty:
    • Daniel Klein, President & CEO, Patient Access Network Foundation
    • Clorinda Walley, CEO, Chronic Disease Fund
    • Patricia Goldsmith, CEO, CancerCare
    • Linda House, BSN, MSN, President, Cancer Support Community
3:15 pm – 4:15 pm
BREAKOUT 5: SUPPLY CHAIN
CAR-T Pipeline and Market Access
  • Moderator: Morrie Ruffin, CEO, Adjuvant Partners
  • Faculty:
    • Amy DuRoss, Co-Founder & CEO, Vineti
    • Joel Brill, MD, CMO, Predictive Health, LLC
BREAKOUT 6: TECHNOLOGY
Big Data: “The New Oil”
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Brad Hirsch, MD, CEO, SignalPath
    • Marcus Neubauer, MD, VP & Medical Director, Value-Based Reimbursement, McKesson Specialty Health
    • IntrinsiQ AmerisourceBergen
BREAKOUT 7: CONTRACTING
Update on the CMS Oncology Care Model and Other Oncology Alternative Payment Models
  • Moderator: Pamela Pelizzari, MPH, Healthcare Consultant, Milliman
  • Faculty:
    • Anand Shah, MD, CMO, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services
    • Michael Ruiz de Somocurcio, VP, Payer & Provider Collaboration, Regional Cancer Care Associates
BREAKOUT 8: BUSINESS
The Burden of Cancer Care: Financial & Nonfinancial Costs Associated with Cancer Diagnosis & Treatment
  • Moderator: Bruce Pyenson, FSA, MAAA, Principal and Consulting Actuary, Milliman
  • Faculty:
    • Christine Ferro, CHFP, Healthcare Analytics Consultant, Milliman
    • Danielle Bubnis, Senior Director, Advocacy, The Leukemia & Lymphoma Society
4:15 pm – 5:15 pm
BREAKOUT 9: CLINICAL
Genomics and Personalized Medicine
  • Moderator: Louis Jacques, MD, ADVI Health LLC
  • Faculty:
    • Stan Skrzypczak, VP, Corporate Development & Reimbursement, Guardant Health
    • Vince Miller, MD, CMO, Foundation Medicine
    • Edward Abrahams, CEO, Personalized Medicine Coalition
BREAKOUT 10: CONTRACTING
Value-Based Oncology Drug Contracting
  • Moderator: Jude Gallagher, PA, MBA, Former Director, Complex Clinical Care Strategy, Humana
  • Faculty:
    • A. Mark Fendrick, MD, Center for Value-Based Insurance Design, University of Michigan
    • James Kenney Jr., RPh, MBA, VP, Harvard Pilgrim Health; President, Academy of Managed Care Pharmacy
    • Brian Bourbeau, MBA, Associate Director, Business Metrics and Analysis, American Society of Clinical Oncology
BREAKOUT 11: SUPPLY CHAIN
Panel: Optimizing Patient Services Solutions in Cancer Care
  • Moderator: Douglas Bock, Partner, Archbow Consulting
  • Learnings:
    • “HUB” types – What Is Really Needed and by Whom?
    • Operational Optimization of Patient and Provider Support Services
    • E-Services and the Evolution to Digitization
  • Pharma Panel Members:
    • Sumner Madden, Senior Director, Access360, AstraZeneca
    • Mike Fitzgibbons, CEO, Claritas Rx
BREAKOUT 12: EMPLOYERS
Cancer Benefit Programs & Employers
  • Moderator: Kevin Host, PharmD, President, COO, Pharmaceutical Strategies Group
  • Faculty:
    • Boeing
    • Southwest Airlines
5:00 pm – 6:00 pm Keynote: Cancer Drug Trend Report
Moderator: Burt Zweigenhaft, Co-Chair, AVBCC
Faculty: Doug Long, VP, Industry Relations, IQVIA
6:00 pm – 7:30 pm Evening Network Reception

Wednesday, October 31

7:00 am – 8:00 am Mini-Roundtables
7:00 am – 7:50 am Breakfast Presentation | Ballroom
Oncology Drug Pipeline Overview, Next 3 Years
  • Moderator: Burt Zweigenhaft, Co-Chair, AVBCC
  • Faculty:
    • Ray Tancredi, RPh, MBA, CSP, Divisional VP, Specialty Pharmacy Development & Brand Rx/Vaccine Purchasing, Walgreens
    • Cheryl Allen, BS, PharmD, MBA, VP, Industry Relations, Diplomat Specialty Pharmacy
7:50 am – 8:00 am Opening Remarks
Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
8:00 am – 8:45 am Keynote
Clifford Hudis, MD, FACP, FASCO, CEO, American Society of Clinical Oncology
Track 1:
CLINICAL
Track 2:
ADVOCACY
Track 3:
TECHNOLOGY
Track 4:
SUPPLY CHAIN
Track 5:
BUSINESS
Track 6:
CONTRACTING
Track 7:
SPECIALTY PHARMACY
Track 8:
EMPLOYERS
8:45 am – 9:45 pm
BREAKOUT 1: BUSINESS
Strategies for Delivering on Pharmaceutical Value, a Focus on Quality
  • Moderator: Darin Rubin, CEO, Managing Director, The Dedham Group LLC
  • Faculty:
    • Danielle Ziernicki, BS, RPh, PharmD, National Quality Forum, Steering Committee for Cancer Project, The Dedham Group LLC
    • Ira Klein, MD, Johnson & Johnson
    • Norris Turner, PharmD, PhD, Pharmacy Quality Alliance
BREAKOUT 2: CLINICAL
Biosimilars and Impact on Cancer Care
  • Moderator: Robert Rifkin, MD, Medical Director, Biosimilars, US Oncology Network
  • Faculty:
    • Mark McClung, General Manager, Global Oncology, Amgen
    • William Yoon, Head, Medical Acct Management & Strategic Alliances, Sandoz
    • Robert Shelley, VP, Biosimilars Account Management, Pfizer
BREAKOUT 3: BUSINESS
The Pharma Food Chain—Driver of Inflation or Obstacle to Innovation?
  • Moderator: Bruce Pyenson, FSA, MAAA, Principal and Consulting Actuary, Milliman
  • Faculty:
    • Richard Evans, Founder and General Manager, SSR LLC
    • Brian DeBusk, CEO & President, DeRoyal; Vice Chair, Lincoln Memorial University; Commissioner, MedPAC
    • Anna Kaltenboeck, Program Director and Senior Health Economist, Center for Health Policy & Outcomes, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center
BREAKOUT 4: BUSINESS
Standardized Measurements and Process for Navigating Cancer Care
  • Faculty:
    • Tricia Strusowski, MS, RN, Manager, Oncology Solutions; Chair, AONN+ Evidence into Practice Metrics Subcommittee
    • Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning & Initiatives, The Lynx Group
9:45 am – 10:45 am Cancer Care Perspectives from Capitol Hill and in Emerging Public Policy
  • Moderator: Marc Samuels, JD, MPH, Managing Partner, ADVI Health LLC
  • Faculty:
    • Kavita Patel, Fellow, Brookings Institution
    • Liz Fowler, VP, Global Health Policy, Johnson & Johnson
10:45 am – 11:30 am
From K Street to Wall Street: A Look at Cancer Policy Influence on Markets
  • Moderator: Ipsita Smolinski, CEO, Capitol Street
  • Faculty:
    • JPMorgan Chase & Co.
    • PNC Bank
Oncology Nurse & Nurse Navigators: Best Kept Secret in Value-Based Care
  • Faculty:
    • Brenda Nevidjon, RN, MSN, FAAN, CEO, Oncology Nursing Society
    • Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning & Initiatives, The Lynx Group
11:30 am – 12:30 pm Understanding Value Equations: Real-World Applications and Implications
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Richard Schilsky, MD, FACP, FASCO, FSCT, SVP & CMO, American Society of Clinical Oncology
    • Peter Bach, MD, Director, Center for Health Policy & Outcomes, Memorial Sloan Kettering Cancer Center
12:30 pm – 1:30 pm Lunch
12:30 pm – 1:15 pm
Clinical Decision Support in the Midst of Rapid Scientific Innovation
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Robert J. Green, MD, SVP, Clinical Oncology, Flatiron Health
    • Anand Shah, MD, MPH, CMO, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services
    • Charles Saunders, CEO, Integra Connect
Patient Panel
  • Moderator: Peter Saltonstall, President & CEO, NORD
1:15 pm – 2:15 pm PANEL DISCUSSION
Pharmacy Benefit Managers & Their Role in Cancer Care Initiatives
  • Moderator: Kevin Cast, Partner, Archbow Consulting
  • Faculty:
    • Everett Neville, RPh, EVP, Strategy, Supply Chain & Specialty, Express Scripts
    • Surya Singh, MD, Corporate VP, Head, Medical Benefit Management, CVS Caremark
    • Optum
2:15 pm – 3:15 pm
BREAKOUT 5: TECHNOLOGY
Blockchain and Use Cases in Cancer Healthcare
  • Moderator: John Bass, Founder, CEO, Hashed Health
BREAKOUT 6: SPECIALTY PHARMACY
Role of the Specialty Pharmacy in Cancer Care
  • Moderator: Mike Ellis, RPh, CEO, Maxor National Pharmacy Services Company
  • Faculty:
    • Ray Bailey, Director of Pharmacy, Florida Cancer Specialists
    • Matt Farber, MS, Senior Director, Walgreens
    • Michael Reff, PharmD, President, National Community Oncology Dispensing Association
    • Brian Seiz, PharmD, President, Accredo Specialty Pharmacy
BREAKOUT 7: EMPLOYERS
Employers and Business Health Coalitions
  • Moderator: Randy Vogenberg, PhD, RPh, Partner, National Institute of Collaborative Healthcare
  • Faculty:
    • David Hom, Chief Evangelist, Scio Health Analytics
BREAKOUT 8: TECHNOLOGY
TITLE
  • Moderator: Jennifer Hinkel, Partner, McGivney Global Advisors
  • Faculty:
    • Verily Life Sciences
    • Center for Medical Technology Policy
    • AmerisourceBergen
3:15 pm – 4:15 pm
BREAKOUT 9: BUSINESS
TOPIC:
  • Moderator:
  • Faculty:
    • Charles Stevens, MBA, JD, VP & Global Lead, Commercialization & Healthcare Communications, ICON plc
BREAKOUT 10: EMPLOYERS
Employers and Managing the Economic Reality of Cancer Spending
  • Moderator: Randy Vogenberg, PhD, RPh, Partner, National Institute of Collaborative Healthcare
BREAKOUT 11: TECHNOLOGY
Value of Digital Medicine & Role in Cancer Care
  • Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
  • Faculty:
    • Josh Stein, Co-Founder, CEO, AdhereTech
BREAKOUT 12: BUSINESS
Future Trends in the Cancer Care Ecosystem
  • Moderator: Jennifer Hinkel, Partner, McGivney Global Advisors
  • Faculty:
    • Brenton Fargnoli, MD, Director, Product Marketing & Strategy/Medical Director, Value-Based Care, Flatiron Health
    • Dan Mendelson, Founder & President, Avalere Health
4:15 pm – 4:30 pm Closing Remarks

*Agenda is subject to change.